FDA: Global Pharma's eye drops contaminated with “filth” while

The US Food and Drug Administration (FDA) lambasted India-based Global Pharma Healthcare in a 14 November warning letter for manufacturing eye drops that have been linked to an outbreak of bacterial infections resulting in consumer injury, blindness, and at least three deaths. In a related enforcement action, FDA also rebuked for making unapproved drug claims.@

PDF) Bottle of Lies The Inside Story of the Generic Drug Boom

Content Analysis of US FDA Warning Letters Issued to Compounding Pharmacies Regarding Violations of Current Good Manufacturing Practices Between 2017 and 2022

The Magazine Insurance Advocate

antibiotic resistance – Page 2 – The Pandora Report

Cosmeceuticals

Untangling Antimicrobial Resistance (AMR) - The Legacy of an unhealthy development model by SocietyForInternationalDevelopment - Issuu

Japan halts use of 1.63 mil Moderna vaccine doses over contamination - Japan Today

USA - PIC/S revises GMP guide to reflect new EU clinical trials regulation

WWW - Fda.gov AboutFDA CentersOffices OfficeofGlobalRegulatoryOperationsandPolicy ORA ORAElectronicReadingRoom Ucm340853, PDF, Food And Drug Administration

Ryoko L. Kawashima, MSc on LinkedIn: The visuals tell the complicated story.

Food Forensics: The Hidden Toxins Lurking in Your Food and How You Can Avoid Them for Lifelong Health (Audible Audio Edition): Mike Adams, Roger Wayne, Blackstone Publishing: Books

Regulatory Affairs Professionals Society (RAPS) on LinkedIn: Quite simply, failure to adhere to cGMP requirements results in…

Road to USP 800 Compliance Archives - Visante

Pharma Regulatory Affairs- API & Formulations